World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 7

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7474)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

308

WORD

HTML

4179

Figures (1-2)

512

Sum=5005

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

245

Download

787

Sum=1032

Publishing Process of This Article

Item

Count

Browse

243

Download

916

Sum=1159

Feb 21, 2024 (publication date) through Apr 22, 2026

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	He QJ, Li YF, Zhao LT, Lin CT, Yu CY, Wang D. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(7): 652-662 [PMID: 38515956 DOI: 10.3748/wjg.v30.i7.652]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i7/652.htm

Number	Citing Articles
1	Haktan Övül Bozkir, Annette Brandt, Katja Csarmann, Anja Baumann, Katharina Burger, Timur Yergaliyev, Tim Hendrikx, Amélia Camarinha-Silva, Ina Bergheim. TNFα is a trigger of aging-associated liver inflammation in mice. npj Aging 2026; 12(1) doi: 10.1038/s41514-025-00326-w
2	Yan Zhang, Lianli Gan, Shixuan Wang, Jinjin Zhang. Gene therapy for aging: Current evidence and future directions. Ageing Research Reviews 2026; 118: 103144 doi: 10.1016/j.arr.2026.103144
3	Lanlan Chen, Paul Horn, Frank Tacke. Providing holistic care for patients with metabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions. Diabetes, Obesity and Metabolism 2026; 28(S2): 46 doi: 10.1111/dom.70545
4	Annette Brandt, Raphaela Staltner, Anja Baumann, Katharina Burger, Julia Jelleschitz, Patricia Oliveira Prada, Annika Höhn, Florian Kopp, Jordi Mayneris-Perxachs, José Manuel Fernández-Real, Ina Bergheim. Toll-like receptor 2 drives liver senescence and fibrosis in aging through gut-derived microbial signaling. Cellular & Molecular Biology Letters 2026; 31(1) doi: 10.1186/s11658-026-00881-4
5	Agnieszka Ziółkiewicz, Przemysław Niziński, Jakub Soja, Tomasz Oniszczuk, Maciej Combrzyński, Adrianna Kondracka, Anna Oniszczuk. Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review. Metabolites 2024; 14(6): 346 doi: 10.3390/metabo14060346
6	David G. Le Couteur, Meng C. Ngu, Nicholas J. Hunt, Amanda E. Brandon, Stephen J. Simpson, Victoria C. Cogger. Liver, ageing and disease. Nature Reviews Gastroenterology & Hepatology 2025; 22(10): 680 doi: 10.1038/s41575-025-01099-z
7	Ren Yoshitomi, Rajeswari Nanda, Kazumi Hirano, Sunil C. Kaul, Jaspreet Kaur Dhanjal, Renu Wadhwa. Ashwagandha withanolides, Withaferin-A, and Withanone for natural interventions in aging and obesity. Mechanisms of Ageing and Development 2025; 228: 112126 doi: 10.1016/j.mad.2025.112126
8	Bicheng Ye, Yuming Teng, Qianqian Chen, Jie Zhang, Shun Li, Li Dong, Changan Xu, Xiao Qiao, Xiaye Miao. Harnessing machine learning for the development, validation, and prognostic evaluation of MASHRisk score: insights from a multicohort study. npj Digital Medicine 2025; 9(1) doi: 10.1038/s41746-025-02220-x
9	Jiaxin Zhao, Huiying Zhou, Rui Wu, Chen Ruan, Cheng Wang, Jiawei Ding, Tao Zhang, Zheyu Fang, Huilin Zheng, Lei Zhang, Jie Zhou, Zhenhua Hu. Biological aging accelerates hepatic fibrosis: Insights from the NHANES 2017–2020 and genome-wide association study analysis. Annals of Hepatology 2025; 30(2): 101579 doi: 10.1016/j.aohep.2024.101579
10	Yangyang Zheng, Ting Li, Shiqi Guo, Jinghai Song. Association of cardiovascular-kidney-metabolic syndrome stages with MASLD prevalence and liver fibrosis severity: evidence from traditional and machine learning approaches. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-04037-0
11	Stavros P. Papadakos, Chara Georgiadou, Eva Kassi, Rallia-Iliana Velliou, Antonios Chatzigeorgiou. Animal models of lean metabolic dysfunction-associated steatotic liver disease (MASLD): bridging pathogenesis and novel drug discovery. Expert Opinion on Drug Discovery 2025; 20(12): 1683 doi: 10.1080/17460441.2025.2579124
12	Xingyu Yuan, Yifeng Hou, Narisu Qin, Lu Xiang, Zhe Jiang, Xiaolan Bao. Flaxseed-derived peptide, Ile-Pro-Pro-Phe (IPPF), ameliorates hepatic cholesterol metabolism to treat metabolic dysfunction-associated steatotic liver disease by promoting cholesterol conversion and excretion. Food & Function 2025; 16(7): 2808 doi: 10.1039/D4FO04478A
13	Dmytro Kryvozub, Tetiana Riabenko, Alina Ponyrko. AGE-RELATED FEATURES OF LIVER CHANGES DURING INTERMITTENT FASTING (LITERATURE REVIEW). Eastern Ukrainian Medical Journal 2025; 13(2): 352 doi: 10.21272/eumj.2025;13(2):352-363
14	Tamer A. Addissouky. Molecular insights into herbal medicines for the treatment of metabolic associated Steatohepatitis. Discover Chemistry 2025; 2(1) doi: 10.1007/s44371-025-00212-0
15	Yue Li, Zixian Li, Siyu Wu, Ling Cao, Beibei Qian, Junxian Tao, Zhimin Qian, Li Xie, Xiaoli Cai, Xiaofang Sun, Ying Li, Zhenwen Zhang, Caifeng Yan, Dunmin She. Association of serum uric acid and serum uric acid/creatinine ratio with metabolic dysfunction-associated fatty liver disease in young adults: a retrospective study. BMC Endocrine Disorders 2026; doi: 10.1186/s12902-026-02236-8
16	Diya Tawk, Ghalia Ghader, Yasmina Khatib, Philippe Attieh, Tya Youssef, Mahmoud Othman, Frederic Harb, Sami Azar, Hilda E. Ghadieh. Nutritional and Fasting Strategies for the Management of MASLD/MASH: An Integrative Review. JGH Open 2025; 9(12) doi: 10.1002/jgh3.70315
17	Julia Markowska, Kamila Kasprzak-Drozd, Przemysław Niziński, Magdalena Dragan, Adrianna Kondracka, Ewa Gondek, Tomasz Oniszczuk, Anna Oniszczuk. Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules 2024; 29(22): 5245 doi: 10.3390/molecules29225245
18	Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Massimo Borelli, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Rocco Spagnuolo, Francesco Luzza. Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine 2025; 14(9): 2973 doi: 10.3390/jcm14092973
19	Olga Sukocheva, Tsai-Wing Ow, Damian Harding, Marc Le Mire, Edmund Tse. Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives. World Journal of Hepatology 2025; 17(7): 106675 doi: 10.4254/wjh.v17.i7.106675 Abstract(358) \| Core Tip(331) \| Full Article(HTML)(1371) \| Full Article with Cover (PDF)-1989K(212) \| Audio-962K(12) \| Peer-Review Report-226K(46) \| Answering Reviewers-155K(43) \| Full Article (PDF)-1762K(110) \| Full Article (XML)-349K(48) \| Times Cited (2) \| Total Visits (3933) \| Open
20	Richard Sprenger, Kat Kiilerich, Mikael Palner, Arsênio Oliveira, Mikaël Croyal, Marie Ostenfeld, Ann Bjørnshave, Gitte Knudsen, Christer Ejsing. Dietary Intake of a Milk Sphingolipid-Rich MFGM/EV Concentrate Ameliorates Age-Related Metabolic Dysfunction. Nutrients 2025; 17(15): 2529 doi: 10.3390/nu17152529
21	Jiwon Yang, Ye Rim Kim, Seong Kyun Na, Seonok Kim, Jihyun An, Ju Hyun Shim. Mortality and Cardiovascular Outcomes in Patients with MAFLD Compared with Patients with MASLD: A Systematic Review and Meta-Analysis. Gut and Liver 2026; 20(1): 137 doi: 10.5009/gnl250275
22	Barnabas Horvath, Judit Halasz, Norman Noel Tanner, Zoltan Marton Kohler, Gyorgy Trencsenyi, Laszlo Juhasz, Laszlo Rovo, Andras Kiss, Aniko Keller-Pinter. Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling. GeroScience 2025; 48(1): 1097 doi: 10.1007/s11357-025-01685-8
23	Min Wu, Yifeng Li, Dong Liu, Weinong Wen, Yan Min, Qiang Su, Zhenxiang An, Xiaofang Yang. Time trends and health inequalities of cirrhosis caused by metabolic Dysfunction-associated steatotic liver disease from 1990 to 2021: A global burden of disease study. Journal of Endocrinological Investigation 2025; 48(11): 2599 doi: 10.1007/s40618-025-02631-3
24	Alexis B. Cruickshank-Taylor, Jacob S. Kozora, Jennifer S. Carew, Steffan T. Nawrocki, Wei Wang. Proteolysis targeting chimeras as senolytics: An emerging senotherapy for combating aging. The Journal of Pharmacology and Experimental Therapeutics 2025; 392(11): 103752 doi: 10.1016/j.jpet.2025.103752
25	Ilaria Milani, Maria Eugenia Parrotta, Luca Colangeli, Marianna Chinucci, Simonetta Palleschi, Barbara Rossi, Paolo Sbraccia, Alessandro Mantovani, Frida Leonetti, Valeria Guglielmi, Danila Capoccia. Sex Differences in MASLD After Age 50: Presentation, Diagnosis, and Clinical Implications. Biomedicines 2025; 13(9): 2292 doi: 10.3390/biomedicines13092292
26	А.А. Antoniv, L.V. Kanovska, O.V. Kaushanska, Yu.M. Yarinich. Metabolic dysfunction-associated steatotic liver disease: epidemiological trends, risk factors, and the role of gut microbiota in disease progression (a literature review). INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2025; 21(6): 656 doi: 10.22141/2224-0721.21.6.2025.1627
27	Feng Zhu, Bing-Ru Lin, Shi-Hua Lin, Chao-Hui Yu, Yun-Mei Yang. Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology 2025; 31(14): 104117 doi: 10.3748/wjg.v31.i14.104117 Abstract(435) \| Core Tip(390) \| Full Article(HTML)(1646) \| Full Article with Cover (PDF)-34957K(177) \| Audio-192K(40) \| Peer-Review Report-228K(72) \| Answering Reviewers-442K(78) \| Supplementary Material-562K(92) \| Full Article (PDF)-34673K(184) \| Full Article (XML)-144K(89) \| Times Cited (2) \| Total Visits (5159) \| Open
28	Vu Thuong Huyen, Kanae Echizen, Ryota Yamagishi, Miho Kumagai, Yoshiki Nonaka, Takahiro Kodama, Tatsuya Ando, Megumu Yano, Naoki Takada, Masaki Takasugi, Fumitaka Kamachi, Naoko Ohtani. Regular exercise suppresses steatosis‐associated liver cancer development by degrading E2F1 and c‐Myc via circadian gene upregulation. Genes to Cells 2024; 29(11): 1012 doi: 10.1111/gtc.13161
29	Yutong Sun, Xingyu Wang, Hongzhi Liu, Xinbo Zhou, Qingquan Ma. Preventive and Ameliorative Effects of Alanine Supplementation on High-Fat Diet–Induced Obesity and Metabolic Dysfunction via the Gut–Liver–Adipose Axis in C57BL/6J Mice. Foods 2026; 15(5): 806 doi: 10.3390/foods15050806
30	Lin Wu, Qi Si, Bin Zhou, Yanyun Che, Yong Liu, Yingying Zhao, Ximei Zhang, Guangyao Shi, Baoshun Hao, Shujie Yu, Xiaoxian Qian, Jianrui Zheng, Dinghui Liu. Ginsenoside Rb1 mitigates senescence-associated hepatic steatosis in mice through enhanced lysine degradation. Journal of Ginseng Research 2026; : 101026 doi: 10.1016/j.jgr.2026.101026